Australia, March 31 -- MIRAI BIO Inc., owns the trademark (2494858) for 'MIRAI' till Sept. 20, 2034.
Status: protected:
Registered/protected
Classes: 40 [Custom manufacture of pharmaceuticals.] and 42 [Pharmaceutical, medical, scientific, and biopharmaceutical research and development; consulting services for others in the field of design, planning, and implementation project management of clinical trials; technical consulting in the field of pharmaceutical studies; consulting services in the field of pharmaceutical research and development; providing on-line non-downloadable software using artificial intelligence, computational methods, and machine learning models for the design and characterization of therapeutic products and drug analysis in the field of drug discovery and development; product development for others in the field of biotechnology and development of pharmaceuticals and therapeutic agents; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceutical preparations and substances for others; research and development of therapeutics related to the discovery, capture, and analysis of data in the field of drug development; providing scientific laboratory services for the discovery, capture, and analysis of data in the field of drug development.]
Type of Mark: Word
Date of Acceptance: Jan. 21
Registration Advertised: March 30
For further details contact Davies Collison Cave Pty. Ltd. and Greenfield & Sacks P.C. Christina M. Licursi Wolf.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2494858.
Disclaimer: Curated by HT Syndication.
